Rachel Weathered

Rachel Weathered joined Novo Holdings in 2025 as an Associate on the Venture Investments team, based in Boston.

Previously, Rachel was an Investment Analyst on the Global Equities team at UBS Asset Management, where she performed fundamental research on public biotech and life sciences companies to inform portfolio investments.

Rachel holds a PhD in Molecular Engineering from the University of Chicago, with a focus in immunoengineering. She also holds a BS in Biomedical Engineering from Northwestern University.